Junk, Stefanie V. http://orcid.org/0000-0001-8206-9463
Förster, Alisa
Schmidt, Gunnar
Zimmermann, Martin http://orcid.org/0000-0002-0365-3512
Fedders, Birthe
Haermeyer, Bernd
Bergmann, Anke K. http://orcid.org/0000-0002-1367-2725
Möricke, Anja
Cario, Gunnar
Auber, Bernd
Schrappe, Martin http://orcid.org/0000-0003-0034-5845
Kratz, Christian P. http://orcid.org/0000-0003-4120-5873
Stanulla, Martin http://orcid.org/0000-0002-3834-0727
Funding for this research was provided by:
Wilhelm Sander-Stiftung (2020.098.1, 2020.098.1)
Deutsche Krebshilfe
TRANSCALL2, ERA-NET TRANSCAN/European Commission under the 7th Framework Programme (FP7), Verein für krebskranke Kinder Hannover e.V., Deutsche José Carreras Leukämie-Stiftung
Article History
Received: 10 September 2023
Revised: 5 February 2024
Accepted: 6 February 2024
First Online: 27 February 2024
Competing interests
: None of the authors has a conflict of interest regarding the present study. Preliminary results of this study were presented in abstract and oral presentation form at the 13th Biennial Childhood Leukemia and Lymphoma Symposium (CLLS) in Valencia, Spain, 7 May 2023.
: The study was approved by the Institutional Review Board of Hannover Medical School, Hannover, Germany, and informed consent was obtained from patients and/or their guardians. Related trial NCT00430118 was registered at ExternalRef removed.